Sponsor

Orexigen Therapeutics, Inc

Clinical research sponsor

Published trials16
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

16 shown
Naltrexone/Bupropion Cardiovascular Outcomes StudyNCT02638129 · lead sponsor · 2016-01-01
TERMINATED
Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two ManufacturersNCT02259179 · lead sponsor · 2014-09-01
COMPLETED
Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese SubjectsNCT01764386 · lead sponsor · 2013-02-01
COMPLETED
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)NCT01601704 · lead sponsor · 2012-06-01
TERMINATED
A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese SubjectsNCT00711477 · lead sponsor · 2008-09-01
COMPLETED
Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic SubjectsNCT00734435 · lead sponsor · 2008-09-01
TERMINATED
Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With ObesityNCT00709371 · lead sponsor · 2008-07-01
COMPLETED
A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major DepressionNCT00624858 · lead sponsor · 2008-01-01
COMPLETED
A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese SubjectsNCT00567255 · lead sponsor · 2007-12-01
COMPLETED
A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese SubjectsNCT00532779 · lead sponsor · 2007-10-01
COMPLETED
A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-DependentNCT00563563 · lead sponsor · 2007-10-01
COMPLETED
A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 DiabetesNCT00474630 · lead sponsor · 2007-05-01
COMPLETED
A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification ProgramNCT00456521 · lead sponsor · 2007-03-01
COMPLETED
Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated ObesityNCT00339014 · lead sponsor · 2006-05-01
COMPLETED
Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated ObesityNCT00364871 · lead sponsor · 2005-04-01
COMPLETED
Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity SurgeryNCT04399395 · collaborator · 2020-11-01
WITHDRAWN

Sponsor roles

lead sponsor15
collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.